House Bill 6797
116th Congress(2019-2020)
CHIPPER Act
Introduced
Introduced in House on May 8, 2020
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
6797
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Susan Wild
grade
Pennsylvania
Alabama
Arizona
California
California
California
California
California
California
California
California
California
California
California
California
California
Colorado
Colorado
Colorado
Connecticut
Connecticut
District of Columbia
Florida
Florida
Florida
Florida
Florida
Georgia
Georgia
Georgia
Illinois
Illinois
Indiana
Iowa
Iowa
Maryland
Maryland
Maryland
Maryland
Michigan
Michigan
Michigan
Michigan
Michigan
Minnesota
Minnesota
Mississippi
Nevada
Nevada
New Jersey
New Jersey
New York
New York
New York
New York
Ohio
Ohio
Ohio
Oregon
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Rhode Island
Rhode Island
Tennessee
Texas
Texas
Texas
Texas
Texas
Texas
Virginia
Virginia
Washington
Washington
Wisconsin
Wisconsin
No House votes have been held for this bill.
Summary
Children's Health Insurance Program Pandemic Enhancement and Relief Act or the CHIPPER Act
This bill extends the 11.5% increase to the enhanced Federal Medical Assistance Percentage (FMAP) that is otherwise applicable under the Children's Health Insurance Program (CHIP) through FY2021, in accordance with specified conditions. For example, in order to receive the increased FMAP in FY2021, a state must cover, without cost-sharing, testing and treatment for COVID-19 (i.e., coronavirus disease 2019), including vaccines, specialized equipment, and therapies.
May 8, 2020
05/08/2020
Referred to the House Committee on Energy and Commerce.
05/08/2020
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:42:57 PM